STE vs PODD — Key Metrics
| Metric | STE (STERIS PLC) | PODD (INSULET CORP) |
|---|---|---|
| Price | 259.57 | 139.98 |
| Market Cap | 25.21 Billion | 9.71 Billion |
| P/E (TTM) | 30.68 | 22.8 |
| P/B (Quarterly) | 3.4 | 7.249 |
| P/S (TTM) | 4.09 | 3.04 |
| Net Profit Margin (TTM) | 13.4 | 13.4 |
| Gross Margin (TTM) | 44.6 | 71.9 |
| ROE (TTM) | 11.5 | 29.5 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Greatly Underperform
Outperform
Recommendation Summary
Stock STE is projected to greatly underperform the market, stock PODD is projected to outperform the market. Upfront Recommendation: PODD.
Financial Metrics
| STE | Metrics | PODD |
|---|---|---|
| $259.57 | Price | $139.98 |
| — | Market Capitalization | — |
| 30.68 | Price to Earnings Ratio | 22.8 |
| 4.09 | Price to Sales | 3.04 |
| 26.6 | Price to FCF Ratio | 41.75 |
| 9.17 | Price to Gross Profit | 4.24 |
| 212.89 | Price to R&D | 26.95 |
| 10.17 | Price to Current Assets | 4.76 |
STE vs PODD at a glance
Steris PLC (STE) and Insulet Corp (PODD) are both Medical Devices companies in the Healthcare sector. STE is the larger, at $25.2 billion in market value against $9.7 billion for PODD, about 2.6 times the size.
On trailing-twelve-month figures, STE trades at 30.7 times trailing earnings and PODD at 22.8; net profit margins are 13.4% and 13.4%.
The Upfront Investment model currently rates STE Greatly Underperform and PODD Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.